Loading…
Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis
Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China. We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge In...
Saved in:
Published in: | PloS one 2016-01, Vol.11 (1), p.e0146659-e0146659 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3 |
container_end_page | e0146659 |
container_issue | 1 |
container_start_page | e0146659 |
container_title | PloS one |
container_volume | 11 |
creator | Huan, Zhou Fuzhi, Wang Lu, Liu Min, Zhang Xingzhi, Chen Shiyang, Jin |
description | Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China.
We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity.
We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%).
ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China. |
doi_str_mv | 10.1371/journal.pone.0146659 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1756066283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A439688031</galeid><doaj_id>oai_doaj_org_article_51f433f0d9314407bb301b3c3762bbb8</doaj_id><sourcerecordid>A439688031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</originalsourceid><addsrcrecordid>eNptUtFqFDEUHUSxtfoHogFBfJmaTGYykz4Iw6K2UFFqfQ43k2Qn62wyJjMrC3682e62tGJeEs49OTnn5mbZS4JPCa3J-5Wfg4PhdPROn2JSMlbxR9kx4bTIWYHp43vno-xZjCuMK9ow9jQ7KlhdMUrZcfZn4dcjBBu9i8gb1KpeB-06jSaPWjfZoKfgNzbAgK5TCcYtsg4BOrfLPr-y8Sf65sd5gMl6t6sseuvgDLXo-zZOep3wDl3pjdW_ETiFvugJ8jb53kYbn2dPDAxRvzjsJ9mPTx-vF-f55dfPF4v2Mu-qqp5y0hhVy7pUlZEgmwLztBSveQ2SGcM5UxIqRSRgwpVJaEGbhDIDhlSNpCfZ673uOPgoDo2LgqQmYMaKhibGxZ6hPKzEGOwawlZ4sOIG8GEpIKQogxYVMSWlBitOSVniWkqKiaQdrVkhpWyS1ofDa7Nca9VpN6XuPRB9WHG2F0u_EWVNcMlxEnh3EAj-16zjJNY2dnoYwGk_73wz3FQlv_H95h_q_9O93bOWkAL0Goapj36Yd38WRVtSzpoGU5KI5Z7YBR9j0ObONcFiN3W38mI3deIwdenaq_uJ7y7djhn9C44m1fE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1756066283</pqid></control><display><type>article</type><title>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Huan, Zhou ; Fuzhi, Wang ; Lu, Liu ; Min, Zhang ; Xingzhi, Chen ; Shiyang, Jin</creator><creatorcontrib>Huan, Zhou ; Fuzhi, Wang ; Lu, Liu ; Min, Zhang ; Xingzhi, Chen ; Shiyang, Jin</creatorcontrib><description>Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China.
We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity.
We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%).
ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0146659</identifier><identifier>PMID: 26756336</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acquired immune deficiency syndrome ; Adhesion ; AIDS ; Analysis ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Antiretroviral Therapy, Highly Active ; China ; Confidence intervals ; Disease transmission ; Dosage and administration ; Genetic transformation ; Health aspects ; Health risks ; Heterogeneity ; HIV ; HIV Infections - drug therapy ; HIV patients ; Human immunodeficiency virus ; Humans ; Medication Adherence ; Meta-analysis ; Patient compliance ; Patients ; Populations ; Pregnancy ; Pregnant women ; Publication Bias ; Regression Analysis ; Regression models ; Risk ; Risk Factors ; Statistical analysis ; Systematic review ; Therapy ; Transformation ; Womens health</subject><ispartof>PloS one, 2016-01, Vol.11 (1), p.e0146659-e0146659</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Huan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Huan et al 2016 Huan et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</citedby><cites>FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1756066283/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1756066283?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25730,27900,27901,36988,36989,44565,53765,53767,75095</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26756336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huan, Zhou</creatorcontrib><creatorcontrib>Fuzhi, Wang</creatorcontrib><creatorcontrib>Lu, Liu</creatorcontrib><creatorcontrib>Min, Zhang</creatorcontrib><creatorcontrib>Xingzhi, Chen</creatorcontrib><creatorcontrib>Shiyang, Jin</creatorcontrib><title>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China.
We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity.
We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%).
ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adhesion</subject><subject>AIDS</subject><subject>Analysis</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>China</subject><subject>Confidence intervals</subject><subject>Disease transmission</subject><subject>Dosage and administration</subject><subject>Genetic transformation</subject><subject>Health aspects</subject><subject>Health risks</subject><subject>Heterogeneity</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV patients</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Medication Adherence</subject><subject>Meta-analysis</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Populations</subject><subject>Pregnancy</subject><subject>Pregnant women</subject><subject>Publication Bias</subject><subject>Regression Analysis</subject><subject>Regression models</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>Statistical analysis</subject><subject>Systematic review</subject><subject>Therapy</subject><subject>Transformation</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUtFqFDEUHUSxtfoHogFBfJmaTGYykz4Iw6K2UFFqfQ43k2Qn62wyJjMrC3682e62tGJeEs49OTnn5mbZS4JPCa3J-5Wfg4PhdPROn2JSMlbxR9kx4bTIWYHp43vno-xZjCuMK9ow9jQ7KlhdMUrZcfZn4dcjBBu9i8gb1KpeB-06jSaPWjfZoKfgNzbAgK5TCcYtsg4BOrfLPr-y8Sf65sd5gMl6t6sseuvgDLXo-zZOep3wDl3pjdW_ETiFvugJ8jb53kYbn2dPDAxRvzjsJ9mPTx-vF-f55dfPF4v2Mu-qqp5y0hhVy7pUlZEgmwLztBSveQ2SGcM5UxIqRSRgwpVJaEGbhDIDhlSNpCfZ673uOPgoDo2LgqQmYMaKhibGxZ6hPKzEGOwawlZ4sOIG8GEpIKQogxYVMSWlBitOSVniWkqKiaQdrVkhpWyS1ofDa7Nca9VpN6XuPRB9WHG2F0u_EWVNcMlxEnh3EAj-16zjJNY2dnoYwGk_73wz3FQlv_H95h_q_9O93bOWkAL0Goapj36Yd38WRVtSzpoGU5KI5Z7YBR9j0ObONcFiN3W38mI3deIwdenaq_uJ7y7djhn9C44m1fE</recordid><startdate>20160112</startdate><enddate>20160112</enddate><creator>Huan, Zhou</creator><creator>Fuzhi, Wang</creator><creator>Lu, Liu</creator><creator>Min, Zhang</creator><creator>Xingzhi, Chen</creator><creator>Shiyang, Jin</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160112</creationdate><title>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</title><author>Huan, Zhou ; Fuzhi, Wang ; Lu, Liu ; Min, Zhang ; Xingzhi, Chen ; Shiyang, Jin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adhesion</topic><topic>AIDS</topic><topic>Analysis</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>China</topic><topic>Confidence intervals</topic><topic>Disease transmission</topic><topic>Dosage and administration</topic><topic>Genetic transformation</topic><topic>Health aspects</topic><topic>Health risks</topic><topic>Heterogeneity</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV patients</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Medication Adherence</topic><topic>Meta-analysis</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Populations</topic><topic>Pregnancy</topic><topic>Pregnant women</topic><topic>Publication Bias</topic><topic>Regression Analysis</topic><topic>Regression models</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>Statistical analysis</topic><topic>Systematic review</topic><topic>Therapy</topic><topic>Transformation</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huan, Zhou</creatorcontrib><creatorcontrib>Fuzhi, Wang</creatorcontrib><creatorcontrib>Lu, Liu</creatorcontrib><creatorcontrib>Min, Zhang</creatorcontrib><creatorcontrib>Xingzhi, Chen</creatorcontrib><creatorcontrib>Shiyang, Jin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huan, Zhou</au><au>Fuzhi, Wang</au><au>Lu, Liu</au><au>Min, Zhang</au><au>Xingzhi, Chen</au><au>Shiyang, Jin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-01-12</date><risdate>2016</risdate><volume>11</volume><issue>1</issue><spage>e0146659</spage><epage>e0146659</epage><pages>e0146659-e0146659</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Reports on antiretroviral therapy (ART) adherence are scare in China; we performed this meta-analysis to estimate ART adherence rates in different populations at high risk for HIV transmission in China.
We searched PubMed, Chinese Biomedical Literature Database (Chinese), China National Knowledge Infrastructure (Chinese), and Wanfang (Chinese) to identify studies published from January 1985 to May 2015. We used random-effects meta-analysis to calculate weighted mean estimates across studies and 95% CIs. Data were pooled with proportions transformed prior to pooling using the Freeman-Tukey double arcsine transformation and then back transformed to the original scale. We calculated the I2 (and its 95% confidence intervals) and tau2 to assess between-study heterogeneity.
We identified 36 eligible articles, including 6885 HIV-positive individuals, reporting ART adherence. Pooled analysis produced an estimate of 77.61% (95% CI = 71.63-83.08) of patients with HIV with adequate adherence; however, high heterogeneity was observed between studies (I2 = 96.60%, 95%CI = 96.00%-97.20%; tau2 = 0.16). Three studies, which included 149 old HIV-infected patients, reported the highest ART adequate adherence rate (89.39%, 95% CI = 72.01-99.26) with high heterogeneity between the studies (I2 = 86.20%, 95%CI = 60.00-95.20%; tau2 = 0.13). While, only two studies, which included 143 heterosexual transmission group (HTG) patients, reported the lowest ART adequate adherence rate (51.55%, 95% CI = 41.33-61.71) with low heterogeneity between the studies (I2 = 31.3%, tau2 = 0.007). In the multivariable meta-regression model, high-risk populations was the main factor explaining heterogeneity (variance explained 28.14%).
ART adherence in some high-risk populations (e.g., heterosexual transmission group) is below the recommended levels for maintaining virologic suppression. It is crucial to develop comprehensive intervention strategies to promote ART adherence in high-risk populations and effectively prevent the spread of HIV/AIDS in China.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26756336</pmid><doi>10.1371/journal.pone.0146659</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2016-01, Vol.11 (1), p.e0146659-e0146659 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1756066283 |
source | Publicly Available Content Database; PubMed Central |
subjects | Acquired immune deficiency syndrome Adhesion AIDS Analysis Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Antiretroviral Therapy, Highly Active China Confidence intervals Disease transmission Dosage and administration Genetic transformation Health aspects Health risks Heterogeneity HIV HIV Infections - drug therapy HIV patients Human immunodeficiency virus Humans Medication Adherence Meta-analysis Patient compliance Patients Populations Pregnancy Pregnant women Publication Bias Regression Analysis Regression models Risk Risk Factors Statistical analysis Systematic review Therapy Transformation Womens health |
title | Comparisons of Adherence to Antiretroviral Therapy in a High-Risk Population in China: A Systematic Review and Meta-Analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T23%3A20%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparisons%20of%20Adherence%20to%20Antiretroviral%20Therapy%20in%20a%20High-Risk%20Population%20in%20China:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=PloS%20one&rft.au=Huan,%20Zhou&rft.date=2016-01-12&rft.volume=11&rft.issue=1&rft.spage=e0146659&rft.epage=e0146659&rft.pages=e0146659-e0146659&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0146659&rft_dat=%3Cgale_plos_%3EA439688031%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c557t-18fd7b74d5fbab8209999d9797ab6ff996dba5d1ba019df7ab2389966faf158b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1756066283&rft_id=info:pmid/26756336&rft_galeid=A439688031&rfr_iscdi=true |